Prosecution Insights
Last updated: April 19, 2026

La Jolla Institute For Immunology

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18556612 ENGINEERED ARENAVIRUS GLYCOPROTEIN COMPOSITIONS, METHODS AND USE THEREOF GILL, RACHEL B 1671 Non-Final OA Oct 20, 2023
18368949 FLAVIVIRUS PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF SALVOZA, M FRANCO G 1672 Final Rejection Sep 15, 2023
18027338 BATF AND IRF4 IN T CELLS AND CANCER IMMUNOTHERAPY SUNSHINE, HANNAH LOUISE 1647 Non-Final OA Mar 20, 2023
18016930 BROADLY NEUTRALIZING BINDING MOLECULES AGAINST MARBURGVIRUSES BUCKMASTER, MARLENE VRENI 1672 Non-Final OA Jan 19, 2023

Managing La Jolla Institute For Immunology's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month